Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP182039.RAq-eJf_eGtCm42STGDnAA3Q89gmwnjIfpqo2f2hn-tkw130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182039.RAq-eJf_eGtCm42STGDnAA3Q89gmwnjIfpqo2f2hn-tkw130_provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP782661.RADZK1eaDcBDsdCstXEwzzwe4_y8No8loS1DhdBPygcio130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782661.RADZK1eaDcBDsdCstXEwzzwe4_y8No8loS1DhdBPygcio130_provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP506705.RAkjpf6tDhCe6bDwvhTw5w6hKofjwGPmplG7BEZ-FwwHQ130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506705.RAkjpf6tDhCe6bDwvhTw5w6hKofjwGPmplG7BEZ-FwwHQ130_provenance.
• NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568922.RA4guFYwg4DPsiQVnWQr6bhWOjCk-_ZsVLtKplr62qoLQ130_provenance.
• NP194017.RAwKHkUpfNj455yN-LXL_vv_LFCnrIABoc9nYtXG_kJ7U130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194017.RAwKHkUpfNj455yN-LXL_vv_LFCnrIABoc9nYtXG_kJ7U130_provenance.
• NP377775.RAMlCUhuqaWHTSVwqWC7QNKpltcU33IWdypcLsN075kvY130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377775.RAMlCUhuqaWHTSVwqWC7QNKpltcU33IWdypcLsN075kvY130_provenance.
• NP567213.RAPe89Uxn2UPWoI1cBeyXvAMcgB8hjAgWV8NecdacuVQE130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567213.RAPe89Uxn2UPWoI1cBeyXvAMcgB8hjAgWV8NecdacuVQE130_provenance.
• NP883226.RAxYXj9ZMR44rzt3QfnXPIsg_r5BvzI3p5EuOCb2Ephe0130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883226.RAxYXj9ZMR44rzt3QfnXPIsg_r5BvzI3p5EuOCb2Ephe0130_provenance.
• NP682923.RAyMGNcwgdYLUFd7myM_bj0wrvfgqoZW_zwtzAAxekjlw130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682923.RAyMGNcwgdYLUFd7myM_bj0wrvfgqoZW_zwtzAAxekjlw130_provenance.
• NP714558.RABqBCzCxjdVkm8eIJoZ_u5wXwFwG9cM10KHmfNTBizEY130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714558.RABqBCzCxjdVkm8eIJoZ_u5wXwFwG9cM10KHmfNTBizEY130_provenance.
• NP365463.RAd3LqcAXs9jEsOBY6KnHNKn4WTVQrZvvc-GSczN57L6g130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365463.RAd3LqcAXs9jEsOBY6KnHNKn4WTVQrZvvc-GSczN57L6g130_provenance.
• NP800560.RAIzoxHNlbpendbMBeFQgIaf5gMOj4tA23uvZO2kqThkU130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800560.RAIzoxHNlbpendbMBeFQgIaf5gMOj4tA23uvZO2kqThkU130_provenance.
• NP656332.RABeABZY_eY_W2527m_PIubBqRIVa5aN-6MzpeKA1iI3Q130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656332.RABeABZY_eY_W2527m_PIubBqRIVa5aN-6MzpeKA1iI3Q130_provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP926834.RAzO_KHF7ZNle2t5XW63QU64eUTKEwoIeNEQ23LWH4ELg130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926834.RAzO_KHF7ZNle2t5XW63QU64eUTKEwoIeNEQ23LWH4ELg130_provenance.
• NP816650.RAV5n7ybYYOnVqNaDcqLgI1qjudrwN_pKk7EuC6xYTD-A130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816650.RAV5n7ybYYOnVqNaDcqLgI1qjudrwN_pKk7EuC6xYTD-A130_provenance.
• NP850500.RAyYF80_9uOXmWGbPbLJJ0qqWwKm_JnEZJIlnYp_RrJRQ130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850500.RAyYF80_9uOXmWGbPbLJJ0qqWwKm_JnEZJIlnYp_RrJRQ130_provenance.
• NP656334.RAxQ3ogicQR-TfslDbs4mjUdX28pfRsyAIx4F3gl9Y6Y4130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656334.RAxQ3ogicQR-TfslDbs4mjUdX28pfRsyAIx4F3gl9Y6Y4130_provenance.
• NP656340.RA5ol45Hmx7P4KXej-RB94HIQehwSKZOkJyoHyEAKSpkg130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656340.RA5ol45Hmx7P4KXej-RB94HIQehwSKZOkJyoHyEAKSpkg130_provenance.
• NP656333.RAeKg2yDb-fzdC5b9AwC0rS6y_z9Si1DW7V2hkAViKRMs130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656333.RAeKg2yDb-fzdC5b9AwC0rS6y_z9Si1DW7V2hkAViKRMs130_provenance.
• NP656336.RAeHRyPWc1RMrvvz3wU2voasm3VP4FOe0jjli332eVcXU130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656336.RAeHRyPWc1RMrvvz3wU2voasm3VP4FOe0jjli332eVcXU130_provenance.
• NP656338.RAcwW-oHoRqCIIrBNS_nW0k6tK7sBu8kGyKUfBrnZns3k130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656338.RAcwW-oHoRqCIIrBNS_nW0k6tK7sBu8kGyKUfBrnZns3k130_provenance.
• NP656341.RAXxLe3Rw98bBRfumqRysoJbXVrh9hYRYPfr0aa0PgxI4130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656341.RAXxLe3Rw98bBRfumqRysoJbXVrh9hYRYPfr0aa0PgxI4130_provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP656335.RANlieCzIch88u9y_EbAQRqoApKfuQcF6vWnBRJZtJ5wQ130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656335.RANlieCzIch88u9y_EbAQRqoApKfuQcF6vWnBRJZtJ5wQ130_provenance.
• NP656343.RAKmd8ydsYg0KXqozLng5wN_ayaJkmXD5vOw2o8k3D2P0130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656343.RAKmd8ydsYg0KXqozLng5wN_ayaJkmXD5vOw2o8k3D2P0130_provenance.
• NP928138.RAqxJFTCc8TiNJ4TV6rnmpV25x3HBmnrEZguruKnWGDZQ130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928138.RAqxJFTCc8TiNJ4TV6rnmpV25x3HBmnrEZguruKnWGDZQ130_provenance.
• NP226270.RAl8wlpP8Xk0HQiqhVGmiXn2DGvXXNZb8S5MdQH7mJPYw130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226270.RAl8wlpP8Xk0HQiqhVGmiXn2DGvXXNZb8S5MdQH7mJPYw130_provenance.
• NP226529.RAjMulzrR4WIISVEFFS8M7ZbInRd124vphDYejXetQw3Y130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226529.RAjMulzrR4WIISVEFFS8M7ZbInRd124vphDYejXetQw3Y130_provenance.
• NP273931.RAtcWpqzIcSfg4ZBYL1il93c4yCYpWYvXw9NZr348FwlI130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273931.RAtcWpqzIcSfg4ZBYL1il93c4yCYpWYvXw9NZr348FwlI130_provenance.
• NP656342.RAmLArXqapKcFUtjD8dIPVgdIuPos22TJJJJ6DZN3BXQA130_assertion description "[Putative loss-of-function mutations in PROKR2 or PROK2, encoding prokineticin receptor-2 (a G protein-coupled receptor), and one of its ligands, prokineticin-2, respectively, have recently been reported in approximately 10% of Kallmann syndrome affected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656342.RAmLArXqapKcFUtjD8dIPVgdIuPos22TJJJJ6DZN3BXQA130_provenance.